TRASTUGET 440 mg (Trastuzumab Injection) is a targeted cancer therapy for patients with HER2‑positive cancers, especially breast cancer and selected gastric cancers. Trastuzumab is a monoclonal antibody that binds to the HER2 protein on cancer cells, helping to slow their growth and improve treatment outcomes. TRASTUGET is administered by intravenous infusion under strict medical supervision and requires ongoing monitoring, including cardiac evaluations and blood tests, throughout treatment. Available in Pakistan through brands such as Trastuget, Herceptin, and other biosimilars, prices vary by supplier and brand. 📌 Quick Notes:

• Active Ingredient: Trastuzumab — a targeted monoclonal antibody against HER2.
• Used For: HER2‑positive breast cancer; also gastric cancer in some cases
• Form: Injection — IV infusion.
• Prescription Required: Yes.